New Ray Medicine International Holding Ltd.
6108.HKHKSEHealthcareMedical - Pharmaceuticals
Latest quote
HK$0.225
+HK$0.016 · +7.66%
6108.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteNew Ray Medicine International Holding Ltd. is an investment company, which engages in the distribution and trading of pharmaceutical products. It operates through the following business segments: Injection Drugs; Capsule and Granule Drugs; Tablet Drugs; Marketing and Promotion Services; and Others. The Injection Drugs segment includes the trading of injection drugs. The Capsule and Granule Drugs segment relates to the selling of capsule and granule drugs. The Tablet Drugs segment comprises tablet drugs. The Marketing and Promotion Services segment focuses in the marketing and promotion of services of drugs. The Others segment trades miscellaneous types of goods and drugs, other than injection drugs, capsule and granule drugs, and tablet drugs. The company was founded on August 9, 2012 and is headquartered in Hangzhou, China.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Qiuqin Wang
- Listed since
- Oct 28, 2013
- Employees
- 31
Market position
52-week range
Current HK$0.225
- Open
- HK$0.225
- Previous close
- HK$0.209
- Volume
- 72K
- 0.79× average
- Average volume
- 91.32K
- Average daily volume
- Market cap
- 45.14M HKD
- Beta
- -3.94
- Market reference 1
- 50-day average
- HK$0.2061
- +9.15% above average
- 200-day average
- HK$0.2284
- -1.49% below average
6108.HK peers
Continue in GoAI
Research 6108.HKresearch.disclaimer